Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Cancer Cell. 2023 Jan 9;41(1):210-225.e5. doi: 10.1016/j.ccell.2022.12.005. Epub 2022 Dec 29.
Cancer Cell. 2023.
PMID: 36584673
Free PMC article.
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial.
Frank MJ, Hossain NM, Bukhari A, Dean E, Spiegel JY, Claire GK, Kirsch I, Jacob AP, Mullins CD, Lee LW, Kong KA, Craig J, Mackall CL, Rapoport AP, Jain MD, Dahiya S, Locke FL, Miklos DB.
Frank MJ, et al.
J Clin Oncol. 2021 Sep 20;39(27):3034-3043. doi: 10.1200/JCO.21.00377. Epub 2021 Jun 16.
J Clin Oncol. 2021.
PMID: 34133196
Free PMC article.
Item in Clipboard
Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma.
Dean EA, Kimmel GJ, Frank MJ, Bukhari A, Hossain NM, Jain MD, Dahiya S, Miklos DB, Altrock PM, Locke FL.
Dean EA, et al.
Blood Adv. 2023 Aug 22;7(16):4608-4618. doi: 10.1182/bloodadvances.2022009426.
Blood Adv. 2023.
PMID: 37126659
Free PMC article.
Item in Clipboard
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy.
Johnsrud A, Craig J, Baird J, Spiegel J, Muffly L, Zehnder J, Tamaresis J, Negrin R, Johnston L, Arai S, Shizuru J, Lowsky R, Meyer E, Weng WK, Shiraz P, Rezvani A, Latchford T, Mackall C, Miklos D, Frank M, Sidana S.
Johnsrud A, et al.
Blood Adv. 2021 Nov 9;5(21):4465-4475. doi: 10.1182/bloodadvances.2021004716.
Blood Adv. 2021.
PMID: 34521106
Free PMC article.
Item in Clipboard
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma.
Baird JH, Frank MJ, Craig J, Patel S, Spiegel JY, Sahaf B, Oak JS, Younes SF, Ozawa MG, Yang E, Natkunam Y, Tamaresis J, Ehlinger Z, Reynolds WD, Arai S, Johnston L, Lowsky R, Meyer E, Negrin RS, Rezvani AR, Shiraz P, Sidana S, Weng WK, Davis KL, Ramakrishna S, Schultz L, Mullins C, Jacob A, Kirsch I, Feldman SA, Mackall CL, Miklos DB, Muffly L.
Baird JH, et al.
Blood. 2021 Apr 29;137(17):2321-2325. doi: 10.1182/blood.2020009432.
Blood. 2021.
PMID: 33512414
Free PMC article.
Item in Clipboard
Cite
Cite